Follitropin beta

促卵泡激素β

Report date: 2023/05/12 14:10:40

Base Information

Drug NameFollitropin beta
Drug Alias Name促卵泡素βRecombinant human follicle (Merck Sharp & Dohme)rhFSH (Merck Sharp & Dohme)促滤泡素-bFollistim AQ Cartridge +[17] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsHypogonadismInfertility, FemalePrimary Ovarian Insufficiency +[4] 
Global Approved IndicationsHypogonadismInfertility, FemaleInfertility
Approved Indications in ChinaHypogonadismInfertility, FemaleInfertility
Original Approved Country/TerritoryEU
Original Approved Date1996/05/02
Country/TerritoryUnited StatesUnited Arab EmiratesEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpMerck Sharp & Dohme BvVetter Pharma-Fertigung Gmbh & Co Kg +[6] 
Inactive CompaniesOrganon Usa Inc
Active IndicationsHypogonadismInfertility, FemalePrimary Ovarian Insufficiency +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeG03GA06
Related LinksDrugBankKEGG